Carregant...
Mortality and Long-Term Virologic Outcomes in Children and Infants Treated with Lopinavir/Ritonavir
BACKGROUND: There is scant data on young children receiving protease inhibitor (PI)-based therapy in real-life resource-limited settings and on the optimal timing of therapy among children who survive infancy. Our aim was to evaluate outcomes at the Hospital del Niño, Panama, where children have bee...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3883902/ https://ncbi.nlm.nih.gov/pubmed/23799516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3182a09276 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|